NVP-BEP800 100mg 100mg | Purity Not Available
Adooq Bioscience
NVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH2-terminal ATP-binding pocket of Hsp90.
More Information Supplier PageNVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH2-terminal ATP-binding pocket of Hsp90.
More Information Supplier PageNVP-BEP800 is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH2-terminal ATP-binding pocket of Hsp90.
More Information Supplier PageAUY922 (NVP-AUY922) is highly potent and oral inhibitor of Hsp90 with IC50=21 nM in Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 average 9 nM.
More Information Supplier PageAUY922 (NVP-AUY922) is highly potent and oral inhibitor of Hsp90 with IC50=21 nM in Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 average 9 nM.
More Information Supplier PageAUY922 (NVP-AUY922) is highly potent and oral inhibitor of Hsp90 with IC50=21 nM in Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 average 9 nM.
More Information Supplier PageAUY922 (NVP-AUY922) is highly potent and oral inhibitor of Hsp90 with IC50=21 nM in Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 average 9 nM.
More Information Supplier PageNVP-BHG712 is a selective inhibitor of EphB4 kinase that exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including FGFR3.
More Information Supplier PageNVP-BHG712 is a selective inhibitor of EphB4 kinase that exhibits selectivity for EphB4 over more than 40 other kinases in vitro, including FGFR3.
More Information Supplier PageNXY-059 is the disulfonyl derivative of the neuroprotective spin trap pheny lbutynitrone or “PBN” with free radical-trapping properties. It substantially lessens the functional disability resulting from cerebral ischemia in a primate species.
More Information Supplier PageNXY-059 is the disulfonyl derivative of the neuroprotective spin trap pheny lbutynitrone or “PBN” with free radical-trapping properties. It substantially lessens the functional disability resulting from cerebral ischemia in a primate species.
More Information Supplier Page